TAVR and more on tap for SCAI 2013 LBCTs

04/22/2013 | CardiovascularBusiness.com

Late-breaking clinical trials to be featured at the SCAI 2013 Scientific Sessions include an assessment of transcatheter aortic valve replacement with procedure transmission, a trial evaluating hydration protocols to prevent contrast medium-induced nephropathy and a study looking at outcomes of angioplasty following carotid stent placement. The annual conference will also offer a symposium on congenital heart disease; coronary, peripheral and structural tracks; and many other sessions.

View Full Article in:

CardiovascularBusiness.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA